Literature DB >> 2428245

Role of calcium channel blockers in clinical medicine.

F Urthaler.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2428245     DOI： 10.1097/00000441-198610000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  3 in total

1.  Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells.

Authors:  L H Block; L R Emmons; E Vogt; A Sachinidis; W Vetter; J Hoppe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 2.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

3.  Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus).

Authors:  H S Bawaskar; P H Bawaskar
Journal:  Br Heart J       Date:  1992-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.